Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023890 (
cirrhosis
)
42,195
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A study of 221 patients revealed that detectable hepatitis B surface antigen (HBS Ag) was found in 16.3% of 49 patients who had
hepatoma
associated with
cirrhosis
. None of the 8
hepatoma
patients without
cirrhosis
had detectable HBS Ag in the serum. When known causes of
cirrhosis
were excluded, HBS Ag was present in 18% of 22 patients. Positive alpha-1-fetoprotein (AFP) was found in 25 of 49 cases (51%) of
hepatoma
with
cirrhosis
but was found only in 1 of 8 cases (12.5%) of
hepatoma
without
cirrhosis
. Of 25 patients whose AFP was positive, HBS Ag was also present in 7. The latter was detected in only 1 of 24 patients in whom AFP was not detected. This study suggests that HBS Ag is closely associated with hepatomas in cirrhotic patients but not in noncirrhotic patients with
hepatoma
.
...
PMID:Relationship of hepatitis B antigen in cirrhosis and hepatoma in Thailand. An etiological significance. 4 28
Serum alpha-fetoprotein levels were measured by radioimmunoassay in 473 patients with biopsy-proved noneoplastic hepatic disorders; 22% had values greater than 40 ng/ml, whereas only 1 of 350 patients with nonhepatic benign diseases had a value greater than this. Levels exceeded 40 ng/ml in more than 30% of patients with various types of hepatitis, and in 0% to 15% with inactive postnecrotic
cirrhosis
, primary biliary cirrhosis, biliary tract obstruction, and alcoholic liver disease. Values greater than 500 mg/ml were observed solely in viral subacute hepatic necrois. Only one patient had a level exceeding 3,000 ng/ml, the concentration at which alpha-fetoprotein is detectable by agar-gel diffusion. Of 75 patients with
hepatoma
, serum alpha-fetoprotein levels exceeded 40 ng/ml in 69%, and exceeded 3,000 ng/ml in 48%. These studies indicate that serum alpha-fetoprotein levels are elevated in several nonneoplastic hepatic disorders when a sensitive assay is used; this phenomenon may reflect hepatic regeneration.
...
PMID:alpha-fetoprotein in noneoplastic hepatic disorders. 4 62
The sera from 89 patients from the Eastern Higlands of Papua New Guinea, all with histologically diagnosed liver disease, were tested for Hepatitis B Antigen (HB Ag) and Hepatitis B antibody (HB Ab) and alpha1 fetoprotein (AFP) by a variety of techniques which included radioimmunoassay. In the three main forms of liver disease, viral hepatitis,
cirrhosis
and
hepatoma
, HB Ag was found with a higher frequency than in patients with non specific liver disease. The frequency of HB Ab was decreased in
cirrhosis
and
hepatoma
. AFP was detected in all
hepatoma
patients by radioimmunoassay, levels being very high in most subjects. In hepatitis,
cirrhosis
and non specific liver disease, elevated levels of AFP were again frequently present, but at generally lower levels. It is conlcuded that HB Ag and AFP frequency and levels in liver disease are similar to those reported from other tropical countries. Further study is required to elicit the cellular immunological changes in liver disease.
...
PMID:Hepatitis B antigen, alpha1 fetoprotein and liver disease in the eastern highlands of Papua New Guinea. 4 12
Five cases of
hepatocellular carcinoma
in whom diagnosis was made when the tumor was relatively small, are described. In 2 cases, serum alpha-fetoprotein (AFP) strted to rise sharply, which enabled early detection and surgical removal of the tumor. Serum AFP was below 100 ng per ml, but above the upper normal limit by radioimmunoassay, and was unfluctuating for a considerable period of time before it began to rise in 2 cases. It was negative throughout in 1 case, who lived more than 4 years after the tumor had reached a detectable size. In 4 of 5 cases, the tumor seemed to have evolved during a stage of chronic hepatitis or its transition to
cirrhosis
. In 1 case with chronic schistosomiasis and advanced mixed macro- and micronodular
cirrhosis
, a 1.5-cm tumor was detected by celiac angiography. These observations on time relationship of oncogenesis may be generalized to modify the cirrhotic liver. Necessity is emphasized for the early detection of this type of carcinoma to monitor serum AFP in chronic hepatitis patients, particularly in those with unfluctuating, mildly abnormal levels of AFP.
...
PMID:Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum alpha-fetoprotein levels. 5 Feb 51
The frequency distribution of HBs Ag in different parts of the world reveals a relatively high frequency among healthy members of population groups inhabiting areas of high incidence of
liver cell carcinoma
. Similar high frequencies of HBs Ag are also found in those areas where macronodular
cirrhosis
is relatively common and is usually complicated by
liver cell carcinoma
. In geographic areas with low incidence of
liver cell carcinoma
and macronodular
cirrhosis
, a relatively low frequency of HBs Ag is usually encountered in the population. The frequency of HBs Ag is relatively higher in patients with
liver cell carcinoma
with or without
cirrhosis
than in comparable controls. The subtypes of the antigen do not correlate with the incidence of
liver cell carcinoma
and there is also no correlation between alpha fetoprotein and HBs Ag in the presence of
liver cell carcinoma
. HBs Ag is very rarely detected in patients with micronodular
cirrhosis
or in
liver cell carcinoma
which may be its complication. It would appear that HBs Ag is necrogenic in the liver and is capable of producing hepatic necroses or hepatitis which may progress to macronodular
cirrhosis
. The areas of hepatic necroses may either progress to
liver cell carcinoma
or the resultant macronodular
cirrhosis
may be complicated by carcinoma. The oncogenic potential of HBs Ag requires further studies.
...
PMID:Hepatitis B surface antigen and liver cell carcinoma. 5 11
Blood from 394 unselected autopsy cases was examined for HB Ag, HB Ab and AFP. Liver morphology of 71 cases of
cirrhosis
with
hepatoma
and 32 cases of
cirrhosis
without
hepatoma
was studied in detail and correlated to HB Ag, HB Ab, and AFP. Significantly lowered humoral immunity to HB Ag exposure was established for the
cirrhosis
with
hepatoma
cases. The exposure rate for both
cirrhosis
cases with
hepatoma
and
cirrhosis
cases without
hepatoma
was the same (48%), but about 80% of each exposed group were either HB Ag or HB Ab positive. The
cirrhosis
with
hepatoma
group tended to be HB Ag positive and the
cirrhosis
without
hepatoma
group tended to be HB Ab positive. The lowered immune response seems to be specific to the
hepatoma
association, because the group with neoplasms other than the
hepatoma
reacted exactly the same as the group of the
cirrhosis
without
hepatoma
. Twenty-five per cent of the
cirrhosis
with
hepatoma
were associated with inactive
cirrhosis
and 75% were associated with active
cirrhosis
. Seventy-two per cent of the inactive
cirrhosis
cases with
hepatoma
were exposed to HB Ag, but only 42% of the active
cirrhosis
cases with
hepatoma
were exposed to HB Ag. On the morphological basis, the inactive
cirrhosis
was interpreted as an impaired cellular immunity and the active
cirrhosis
as a delayed hypersensitivity reaction. The possibility was discussed that both are important factors in the development of
hepatoma
preceded by
cirrhosis
. AFP tends to be positive in the inactive
cirrhosis
with
hepatoma
as well as HB Ag, but the relationship between AFP and HB Ag for hepatocarcinogenesis needs further investigation.
...
PMID:Alpha-Fetoprotein and hepatitis B antigen in hepatocarcinogenesis. 5 18
(1) Passive hemagglutination and radioimmunoassay are suitable methods for the detection of AFP in the low concentration range. (2) In 3.72% of the cases a clinically unknown carcinoma was found in an unselected group of patients with
liver cirrhosis
. (3) 21.9% of the patients showed AFP elevations up to 2000 ng/ml. In 10.6% of this group, increasing titers demonstrated a primary
liver cell carcinoma
. In 89.4% a transitory rise of AFP was not associated with tumor growth. Levels return to normal values within three months in 90% of the cases. (4) Transitory AFP elevations are not correlated to clinical conditions (praecoma, coma, delirium, bleeding, ascites, shunt) or to biochemical parameters (GOT, GPT, bilirubin, prothrombin complex time, gamma-globulin). (5) A temporary rise in AFP is more frequently observed in groups with high
hepatoma
incidence than in groups with low
hepatoma
incidence. (6) Therefore, it may be suggested that a transitory rise of AFP could reflect a "primary reaction" of carcinogenesis. (7) Primary
liver cell carcinoma
is found to be more frequent in posthepatitic than in postalcoholic, cryptogenic, and other
cirrhosis
and to be more frequent in australia-antigen positive than in australia-antigen negative cases. (8) Routine serological tumor antigen screening of patients with a precancerous disease is useful.
...
PMID:Early detection of hepatoma: prospective study in liver cirrhosis using passive hemagglutination and the radioimmunoassay. 5 21
Blood and liver from 44 and 30 patients, died in
cirrhosis
and other diseases, respectively were tested for the presence of HBSAg. Blood samples obtained at autopsy and in seven
cirrhosis
cases also before death were tested for HBSAg by counter-electrophoresis. Detection of HBSAg in hepatocytes was carried out in paraffin sections by the modified orcein staining technique of Shikata et al. Ten of 14 HBSAg seropositive and 2 of 30 HBSAg seronegative cirrhotic patients had orcein positive hepatocytes, which were not found in any liver specimen from the 30 non-cirrhotic seronegative patients. The orcein positive substance localized in the cytoplasm of hepatocytes, less often it was also seen in a few Kupffer cells. The
hepatocellular carcinoma
cells present in part of the livers studied did not contain any orcein positive substance. Histological changes in the cirrhotic livers showed morphological indication of the presence of HBSAg, except on staining with orcein. The modified orcein staining technique is a simple, handy procedure for use in any routine pathological laboratory and has the additional advantage of detecting HBSAg also in stored paraffin blocks.
...
PMID:Demonstration of hepatitis B surface antigen by orcein staining in paraffin sections of cirrhotic liver. 5 4
The plasma level of alpha1-fetoprotein in 35 hepatic patients with a "cold" area showed by liver scanning has been detected by means of the radioimmunoassay technique. High levels (more than 320 ng/ml) of AFP were found in 4 cases of primary carcinoma of the liver; low concentration of AFP was found in 1 case of
hepatoma
. In 4 cases of liver metastasis the plasma levels of AFP were very low; the highest concentration (10 ng/ml) was found in a patient with a cancer of the colon. Low levels of AFP were found in all the cases (26) of
hepatic cirrhosis
, whereas high level of AFP was detected in 1 case of chronic hepatitis. The detection of alpha1-fetoprotein by the radioimmunoassay technique may be of value in the differential diagnosis between
hepatoma
and
cirrhosis
.
...
PMID:[Radioimmunologic determination of alpha fetoprotein in diagnosis of primary tumors of the liver]. 5 25
A radioimmunoassay method was used for the detection of alpha fetoprotein (AFP) in the sera of 112 Papua New Guinean patients who had undergone liver biopsy. Sera from 69 normal subjects and 20 hospital patients were also tested. Alpha fetoprotein was found to be elevated above normal levels in many of these subjects, but particularly in those suffering from viral hepatitis,
cirrhosis
and primary
liver cell carcinoma
(PLC). The highest values were found in patients with PLC. It is concluded that because of the elevation of AFP values in all these different types of liver disease the RIA test is not of great value in Papua New Guinea, except in the follow-up of some patients with
cirrhosis
who are at risk of developing PLC and in those who have undergone treatment for PLC.
...
PMID:Alpha fetoprotein in liver disease in Papua New Guinea. 6 51
1
2
3
4
5
6
7
8
9
10
Next >>